- Home
- TME vs IQV Comparison
TME vs IQV Comparison
Compare TME & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TME
- IQV
- Stock Information
- Founded
- TME N/A
- IQV 1982
- Country
- TME China
- IQV United States
- Employees
- TME N/A
- IQV N/A
- Industry
- TME Broadcasting
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TME Consumer Discretionary
- IQV Health Care
- Exchange
- TME Nasdaq
- IQV Nasdaq
- Market Cap
- TME 28.5B
- IQV 27.2B
- IPO Year
- TME 2018
- IQV 2013
- Fundamental
- Price
- TME $21.43
- IQV $160.71
- Analyst Decision
- TME Strong Buy
- IQV Buy
- Analyst Count
- TME 6
- IQV 20
- Target Price
- TME $15.00
- IQV $222.55
- AVG Volume (30 Days)
- TME 6.2M
- IQV 1.9M
- Earning Date
- TME 08-12-2025
- IQV 07-22-2025
- Dividend Yield
- TME 0.84%
- IQV N/A
- EPS Growth
- TME 84.42
- IQV 0.26
- EPS
- TME 0.84
- IQV 7.35
- Revenue
- TME $3,994,901,125.00
- IQV $15,497,000,000.00
- Revenue This Year
- TME $11.06
- IQV $5.33
- Revenue Next Year
- TME $11.97
- IQV $4.99
- P/E Ratio
- TME $26.67
- IQV $22.22
- Revenue Growth
- TME 5.35
- IQV 2.84
- 52 Week Low
- TME $9.41
- IQV $134.65
- 52 Week High
- TME $22.50
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- TME 66.83
- IQV 53.25
- Support Level
- TME $19.57
- IQV $156.16
- Resistance Level
- TME $22.50
- IQV $168.97
- Average True Range (ATR)
- TME 0.64
- IQV 5.06
- MACD
- TME 0.13
- IQV -0.58
- Stochastic Oscillator
- TME 70.91
- IQV 40.23
About TME Tencent Music Entertainment Group each representing two
Tencent Music is the largest online music streaming platform in China, established in 2016 through the merger of QQ Music, Kuwo Music, and Kugou Music. Tencent, its largest shareholder, holds over 50% of the shares and more than 90% of the voting rights. Beyond streaming services, Tencent Music generates revenue through a diverse range of offerings, including podcasts, livestreaming, concerts, and karaoke.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.